Bausch Health Cos
Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, gastrointestinal health, and dermatology. With a diverse portfolio of innovative products, Bausch Health is renowned for its commitment to improving patient outcomes through advanced therapies and technologies. Key offerings include prescription medications, over-the-counter products, and surgical devices, all designed to address critical health needs. Bausch Health has achieved significant milestones, including strategic acquisitions that have bolstered its market position. The company continues to be a leader in the healthcare sector, dedicated to enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bausch Health Cos's score of 39 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bausch Health Cos's reported carbon emissions
In 2023, Bausch Health Cos reported total greenhouse gas emissions of approximately 49,906,000 kg CO2e for Scope 1 and about 65,518,000 kg CO2e for Scope 2. Additionally, their Scope 3 emissions included approximately 11,467,000 kg CO2e from capital goods, 38,011,000 kg CO2e from purchased goods and services, 5,380,000 kg CO2e from waste generated in operations, and 3,187,000 kg CO2e from fuel and energy-related activities. Bausch Health has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2020 as the base year. This target has been validated by the Science Based Targets initiative (SBTi) and reflects the company's commitment to align with the necessary reductions to limit global warming to 1.5°C. The company also plans to measure and reduce its Scope 3 emissions, demonstrating a comprehensive approach to tackling its overall carbon footprint. Overall, Bausch Health's emissions data and reduction targets highlight its proactive stance on climate action, contributing to a more sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2018 | 2019 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 547,180,000 | 000,000,000 | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Cos is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
